Researchers have identified a pair of genes which appear to be responsible for allowing a specific strain of bacteria in the human gut to break down Lanoxin -- a widely prescribed cardiac drug -- into an inactive compound, as well as a possible way to turn the process off.
Read more...
Read more...
No comments:
Post a Comment